BioElectronics Expands in the UK Market Leading UK Retailer, Superdrug to market and sell ActiPatch® Pain Therapy
FREDERICK, Md., Nov. 9, 2015 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that it has received an initial order for its ActiPatch® Musculoskeletal Pain Relief products from Superdrug pharmacies. Superdrug is a subsidiary of the A.S. Watson Group, the world's largest international health and beauty retailer with 12,000 stores. Superdrug will promote BioElectronics' 7-Day Trial Device, Try & Tell Marketing Campaign online and stock ActiPatch in 186 stores in mid-November.
"Superdrug will promote BioElectronics 7-Day Trial Device, to create product demand on their web site," said Ben Fichter, Marketing Director, BioElectronics Corporation. "We are looking forward to collaborating with this innovative retailer to extend our successful marketing program into the retail environment."
I am a trader, only a trader. my posts are my opinion and are not for sale. I do my DD, I advise you to do yours. My posts are not recommendations to buy or sell. I have never and will not accept payment to post on any stock. So don't ask.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.